Direct conversion of human blood cells into neural stem cells erases nearly all epigenetic age over a protracted fifty-day ...
The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based ...
Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company advancing blood- and cell-based therapies ...
Researchers have discovered a new cell type that may help regulate blood vessel growth in the heart during development and in response to injury ...
Scientists are using cell-free transcription and translation systems to synthesize proteins, design biology-based sensors and ...
EPCORE DLBCL-2 is the first Phase 3 study of a bispecific antibody combination therapy to demonstrate statistically significant and clinically meaningful improvement in progression-free survival (PFS) ...
EPCORE DLBCL-2 is the first Phase 3 study of a bispecific antibody combination therapy to demonstrate statistically significant and clinically meaningful improvement in progression-free survival (PFS) ...
In addition to their established role in fighting pathogens, certain maternal immune cells (neutrophils) can support early ...
A new review details how the Runx1 and Gata2 transcription factors architect the epigenetic landscape of blood formation and ...
In addition to their established role in fighting pathogens, certain maternal immune cells (neutrophils) can support early ...
The Nose Knows More Than You Think A shark's nostrils do not breathe. They are dedicated scent organs, and nothing else.
Imugene Reports New Responses With Azercabtagene Zapreleucel Plus BTK Inhibitor in Phase 1b Blood Cancer Trial / allogeneic ...